A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/535 (2006.01) A61K 31/5377 (2006.01) A61K 31/5415 (2006.01) A61P 25/00 (2006.01) A61P 25/18 (2006.01) A61P 43/00 (2006.01) A61K 31/445 (2006.01) C07D 413/06 (2006.01)
Patent
CA 2334609
The present invention provides the use of a NK-1 receptor antagonist for the manufacture of a medicament adapted for oral administration for the treatment or prevention of schizophrenic disorders, substance use disorders and movement disorders, methods of treatment using such a NK-1 receptor antagonist and pharmaceutical compositions and products comprising the same.
La présente invention concerne l'utilisation d'un antagoniste du récepteur NK-1 (neurokinine 1) pour la fabrication d'un médicament, administrable par voie orale, intervenant dans le traitement ou la prévention de troubles schizophréniques, de troubles liés à l'utilisation de certaines substances et de troubles de la mobilité ainsi que des techniques de traitement médical au moyen d'un tel antagoniste du récepteur NK-1 et des compositions pharmaceutiques et des produits renfermant ledit antagoniste.
Merck Sharp & Dohme Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Use of a nk-1 receptor antagonist for treating psychiatric... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a nk-1 receptor antagonist for treating psychiatric..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a nk-1 receptor antagonist for treating psychiatric... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1724478